SCHEMBL6933414

SCHEMBL6933414

Cc1c(C(=O)Nc2c(Cl)cccc2C(=O)O)noc1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMURF1 Q9HCE7 5/20 0.49
MAPT P10636 3/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
DUSP3 P51452 3/20 0.42
PTGER4 P35408 1/20 0.42
PTPN1 P18031 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PTGS2 P35354 2/20 0.41
USP2 O75604 1/20 0.41
MT-CO2 P00403 1/20 0.41
TTR P02766 1/20 0.41
PLA2G1B P04054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818254 0.79 SERPINE1 (0.57) SMURF1MAPTKDM4EAKR1C3
SCHEMBL6818811 0.74 AKR1C2 (0.48) MAPTMEN1KMT2AAKR1C3POLB
SCHEMBL4076415 0.74 PTPN1 (0.67) SMURF1MAPTKDM4EMEN1KMT2A
SCHEMBL27287798 0.72 POLB (0.59) MAPTKDM4EMEN1LMNAKMT2A
SCHEMBL6822210 0.72 ALDH1A1 (0.43) MEN1KMT2ADUSP3PTPN1POLB
SCHEMBL10743840 0.72 KMT2A (0.64) MAPTKDM4EMEN1LMNAKMT2A
SCHEMBL768632 0.70 PTPN1 (0.56) MAPTKDM4EMEN1KMT2ADUSP3
SCHEMBL12000495 0.69 PTGS1 (0.60) MAPTKDM4EDUSP3PTPN1SMN1; SMN2
SCHEMBL21932440 0.69 PTPN1 (0.54) MAPTKDM4EMEN1LMNAKMT2A
SCHEMBL4337496 0.69 DUSP3 (0.56) SMURF1DUSP3PTPN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 SMURF1 712/4885MAPT 4759/4885KDM4E 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.